# Nephron Sc Inc – FDA Inspection, Apr 20, 2018

Source: https://www.keypedia.com/records/fda_inspections/nephron-sc-inc/30630574-253e-4e24-a3aa-191bbe46c7b8
Source feed: FDA_Inspections

> FDA inspection 1049382 of Nephron Sc Inc, April 20, 2018. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. Form 483 issued. 12 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1049382
- Company Name: Nephron Sc Inc
- Inspection Date: 2018-04-20
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- [FDA Inspection 1274364 - 2025-08-22](https://www.keypedia.com/records/fda_inspections/nephron-sc-inc/cbad2da2-21ae-41c8-8520-a2c9826226d4)
- [FDA Inspection 1247772 - 2024-09-25](https://www.keypedia.com/records/fda_inspections/nephron-sc-inc/8d6892d9-27b4-4159-a498-fc8bfe4ed24c)
- [FDA Inspection 1229051 - 2024-02-09](https://www.keypedia.com/records/fda_inspections/nephron-sc-inc/7610bef4-1d7f-4cb3-bd8f-ee549586e73d)
- [FDA Inspection 1197994 - 2023-02-10](https://www.keypedia.com/records/fda_inspections/nephron-sc-inc/5c6a8c2a-0cd7-4f46-bc21-9f3d518ae97d)
- [FDA Inspection 1168119 - 2022-04-20](https://www.keypedia.com/records/fda_inspections/nephron-sc-inc/dbba7c32-d2ce-4576-b4c6-077bb9144c98)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/larry-k-hampton/de10767b-b25b-4d55-bfe2-60ea51c828f6)
- [Seneca D. Toms](https://www.keypedia.com/people/seneca-d-toms/3eda62a2-4c12-438f-805a-5e3efb0f2f94)

Company: https://www.keypedia.com/companies/nephron-sc-inc/2dadfd52-37b7-4da6-9885-864d470c1b18

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c